(Q42910434)

English

Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT).

scientific article published on 16 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). (English)

1 reference

Europe PubMed Central

11 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Buddha Basnyat

1 reference

Europe PubMed Central

11 November 2017

Robert S Fisher

6

object named as

Robert S Fisher

0 references

author name string

Jeffrey H Gertsch

1

1 reference

Europe PubMed Central

11 November 2017

Grant S Lipman

2

1 reference

Europe PubMed Central

11 November 2017

Peter S Holck

3

1 reference

Europe PubMed Central

11 November 2017

Andrew Merritt

4

1 reference

Europe PubMed Central

11 November 2017

Allison Mulcahy

5

1 reference

Europe PubMed Central

11 November 2017

Robert S Fisher

6

1 reference

Europe PubMed Central

11 November 2017

Eric Allison

8

1 reference

Europe PubMed Central

11 November 2017

Keeli Hanzelka

9

1 reference

Europe PubMed Central

11 November 2017

Alberto Hazan

10

1 reference

Europe PubMed Central

11 November 2017

Zachary Meyers

11

1 reference

Europe PubMed Central

11 November 2017

Justin Odegaard

12

1 reference

Europe PubMed Central

11 November 2017

Benjamin Pook

13

1 reference

Europe PubMed Central

11 November 2017

Mark Thompson

14

1 reference

Europe PubMed Central

11 November 2017

Brant Slomovic

15

1 reference

Europe PubMed Central

11 November 2017

Henrik Wahlberg

16

1 reference

Europe PubMed Central

11 November 2017

Vanessa Wilshaw

17

1 reference

Europe PubMed Central

11 November 2017

Eric A Weiss

18

1 reference

Europe PubMed Central

11 November 2017

Ken Zafren

19

1 reference

Europe PubMed Central

11 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 June 2010

1 reference

Europe PubMed Central

11 November 2017

Wilderness and Environmental Medicine

1 reference

Europe PubMed Central

11 November 2017

21

1 reference

Europe PubMed Central

11 November 2017

3

1 reference

Europe PubMed Central

11 November 2017

236-243

1 reference

Europe PubMed Central

11 November 2017

Acute mountain sickness in a general tourist population at moderate altitudes

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Clinical features of headache at altitude: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

High altitude headache. A prospective study of its clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

High-Altitude Illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

High altitude cerebral edema.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Response properties of dural nociceptors in relation to headache

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Sensitization of meningeal sensory neurons and the origin of headaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Over-the-counter analgesics and antipyretics: a critical assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Effects of aspirin during exercise on the incidence of high-altitude headache: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

The effect of naproxen on acute mountain sickness and vascular responses to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

The minimum clinically important difference in physician-assigned visual analog pain scores

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Prospective validation of clinically important changes in pain severity measured on a visual analog scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Sensitization of meningeal nociceptors: inhibition by naproxen

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Cerebral blood flow in man at high altitude. Role of cerebrospinal fluid pH in normalization of flow in chronic hypocapnia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Doppler study of middle cerebral artery blood flow velocity and cerebral autoregulation during a simulated ascent of Mount Everest.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

1 reference

https://api.crossref.org/works/10.1016%2FJ.WEM.2010.06.009

7 January 2021

Identifiers

10.1016/J.WEM.2010.06.009

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42910434&oldid=2112461640"